PROSTATE CANCER RESEARCH INSTITUTE (EIN 954617875) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1997

Legal Domicile

Phone

3107432116

Tax Period

2024-07-01 to 2025-06-30

PROSTATE CANCER RESEARCH INSTITUTE, founded in 1997, is a community nonprofit in the Medical Research sector that reported $1.6M in total revenue in fiscal year 2024. Revenue grew 17% year-over-year, indicating healthy expansion. The organization ran a surplus of $375K, a strong 23% operating margin.

Mission

EDUCATE ON THE DIAGNOSIS, TREATMENT AND POST-TREATMENT OF PROSTATE CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,134,841

Program Service Revenue $348,877

Investment Income $114,140

Other Revenue $32,686

TOTAL REVENUE $1,630,544

Expense Breakdown

Grants Paid $0

Salaries & Benefits $807,814

Fundraising Expenses $42,543

Program Expenses $1,128,464

Other Expenses $448,140

TOTAL EXPENSES $1,255,954

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,630,544	$1,391,142	+0.2%
Expenses	$1,255,954	$978,752	+0.3%
Net Income	$374,590	$412,390	-0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ALEX SCHOLZ	KEY EMPLOYEE	40.00		$147,950	$26,300	$174,250
Mark C Scholz MD	Executive Dir.	66.00	Officer Director	$0	$0	$0
Chester A Swenson	President	3.00	Officer Director	$0	$0	$0
Michael L Steinberg MD	Vice President	1.00	Officer Director	$0	$0	$0
Steve Schwartz	Director	1.00	Director	$0	$0	$0
John D Anderson	Treasurer	1.00	Officer Director	$0	$0	$0
David T Robinson Jr	Director	1.00	Director	$0	$0	$0
Richard Citron	Secretary	1.00	Officer Director	$0	$0	$0
Stanley A Brosman MD	Director	1.00	Director	$0	$0	$0
Arthur N Lurvey MD	Director	2.50	Director	$0	$0	$0
Jerry E Peters	Director	1.00	Director	$0	$0	$0
Scott M Cohen	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,630,544	$1,255,954	$3,087,250	$374,590
2024	$1,391,142	$978,752	$2,552,630	$412,390
2023	$832,031	$998,461	$2,058,566	$-166,430
2022	$999,786	$868,556	$2,240,081	$131,230
2021	$714,337	$752,386	$2,195,484	$-38,049
2020	$642,814	$906,403	$2,217,805	$-263,589
2019	$2,014,750	$760,342	$2,380,525	$1,254,408
2018	$735,915	$821,560	$1,124,099	$-85,645

PROSTATE CANCER RESEARCH INSTITUTE